TLR4 and metabolic dysfunction-associated steatotic liver disease: Wagnerberger et al. [75] proved that the administration of Lactobacillus casei strain Shirota probiotic are found to mitigate fructose-driven NAFLD by attenuating the hepatic Toll-like receptor 4 signaling cascade.